Contributor Page
Ropes & Gray LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 5969000
Fax: +1 212 5969090
1211 Avenue of the Americas
New York
New York
NY 10036-8704
United States
By Isabel K.R. Dische, Brett A. Robbins, Cameron Casey
In a recently released Ropes & Gray podcast, asset management partner Isabel Dische, tax partner Brett Robbins, and private client partner Cameron Casey discuss the effect of Section 457A ...
By Katherine Wang
On May 19, 2017, China's State Council promulgated the amendments to the 2014 Regulation on the Supervision and Administration of Medical Devices ("the Amendments"), which became effective immediately.
By Ropes & Gray LLP's ERISA Practice
On May 22, 2017, the U.S. Department of Labor (the "DOL") released a new set of FAQs confirming that the compliance date for the fiduciary rule will remain June 9, 2017 (with compliance required...
By Timothy McCrystal, Deborah Gersh, Jennifer Romig
We discuss below key regulatory challenges and mitigation strategies for consideration during the transition to value-based care.
By John Chesley
Health care M&A transactions are subject to the larger industries' ups and downs – and winners and losers, of course, are a shift from one sector to another over time depending on external pressures, particularly the payment system pressures.
By Thomas N. Bulleit, Albert F. Cacozza, Jr., Kellie Coombs, Colleen Conry, Gregory Levine, Paul Rubin
On Tuesday, May 2, Ropes & Gray hosted a teleconference, "Outlook 2017 Teleconference: Revisiting the Trump Administration's Impact on Life Sciences and Health Care – the First 100 Days," on the potential regulatory and compliance impact of the Trump Administration on life sciences and health care companies.
By Leslie Spencer, Matthew Rizzolo
On May 22, 2017, in TC Heartland LLC v. Kraft Foods Group Brands LLC, the Supreme Court unanimously overturned nearly thirty years of Federal Circuit law regarding venue in patent infringement cases, ..
By Michael Littenberg, Amanda Raad, Andrew Dale, Marcus Thompson
Most companies will be publishing their first statements under the UK Modern Slavery Act towards the end of the first half of 2017.
By Heather Egan Sussman, Deborah Gersh, Timothy McCrystal, Douglas Meal, James DeGraw, Seth Harrington, Mark Szpak, Michelle Visser, Elizabeth McCann, Jessica Alfano
The WannaCry ransomware attack that hit computers around the world last week is yet another reminder that computers play key roles in most enterprises, and that it does not take much to disable those computers.
By Heather Egan Sussman, James DeGraw, Rohan Massey, Douglas Meal, Seth Harrington, David McIntosh, Mark Szpak, Michelle Visser, Paul Rubin, Marc Berger, Laura Hoey, David Cohen, Daniel Freshman
On May 11, 2017, President Donald J. Trump signed an executive order addressing cybersecurity risk management across three key areas: (1) federal government networks...
By Ropes & Gray LLP's Health Care Practice, Ropes & Gray LLP's Government Enforcement/White Collar Crime Practice, Ropes & Gray LLP's Anti-Corruption / International Risk Practice
Over the past 15 years, pharmaceutical manufacturers, medical device companies, and other participants in the health care industry have been regular targets of FCPA enforcement actions brought by the U.S. government.
By Katherine Wang
Further legislative initiatives will be arranged if any parts of the draft policies contradict the current CFDA regulations.
By Megan Baca, Henry Huang, Matthew Rizzolo
The pending Supreme Court case of Impression Products v. Lexmark International could affect what companies and consumers do with products they buy, based on the doctrine of patent exhaustion.
By Rohan Massey, Clare Sellars
The General Data Protection Regulation (the "GDPR") came into force in May 2016 and makes numerous changes to European data protection laws.
By Deborah Gersh, Timothy McCrystal, Christina Bergeron
This article highlights key business and legal issues related to value-based healthcare for investors considering opportunities in the healthcare industry.
Contributor's Topics